Results 121 to 130 of about 102,850,963 (222)

The Dengue ED3 Dot Assay, a Novel Serological Test for the Detection of Denguevirus Type-Specific Antibodies and Its Application in a Retrospective Seroprevalence Study

open access: yesViruses, 2019
There are four distinct antigenic serotypes of dengue viruses (DENV-1-4). Sequential infections with different serotypes lead to cross-reactive but also serotype-specific neutralizing antibody responses.
Heidi Auerswald   +9 more
doaj   +1 more source

Additional file 2: of Screening for differentially expressed miRNAs in Aedes albopictus (Diptera: Culicidae) exposed to DENV-2 and their effect on replication of DENV-2 in C6/36 cells

open access: yes, 2019
Table S2. Annotations of clean sRNAs from the midguts of infected Ae. albopictus after a DENV-2-infected blood meal. (DOCX 21 kb)
Su, Jianxin   +9 more
openaire   +1 more source

Cross-reactive DENV-specific serum neutralization during secondary DENV infections.

open access: yes, 2012
A. DENV-specific neutralization of the serum at 3 months post-onset of symptoms in 2° DENV-3 infections. Longitudinal serum samples, obtained 3 months post-onset of symptoms from a subset (n = 20) of 2° DENV-3 infections, were analyzed in a flow ...
Eva Harris (27355)   +4 more
core   +1 more source

Identifying the strains of dengue circulating in the western province of Sri Lanka during 2019-2022.

open access: yesPLOS Global Public Health
A study conducted from July 2019 to May 2022 at several hospitals in the Western Province, Sri Lanka, focused on dengue virus strains during the COVID-19 pandemic. Among 417 febrile patients, 47% were PCR-positive for dengue.
Harshi Abeygoonawardena   +15 more
doaj   +1 more source

A NEW COPPER (II)-IMIDAZOLE DERIVATIVE EFFECTIVELY INHIBITS REPLICATION OF DENV-2 IN VERO CELL

open access: yesAfrican Journal of Infectious Diseases, 2018
Dengue is a kind of infectious disease that was distributed in the tropical and sub-tropical areas. To date, there is no clinically approved dengue vaccine or antiviral for humans, even though there have been great efforts towards this end. Therefore, finding the effective compound against dengue virus (DENV) replication is very important.
Teguh Hari Sucipto, .-   +9 more
openaire   +3 more sources

Serum cytokine profiles observed after infection with DENV-1 0111/2011, DENV-2 0126/2010 or DENV-4 BEL 83791.

open access: yes, 2018
Sera collected before (baseline) and at days 1, 4, 6, 8 and 14 after DENV inoculation were tested, in duplicate, for their concentration in the indicated cytokines. Results were expressed as pg/mL.
Michael Cruz (5142977)   +16 more
core   +1 more source

Emergence of new genotypes and lineages of dengue viruses during the 2012–15 epidemics in southern India

open access: yesInternational Journal of Infectious Diseases, 2019
Objectives: To genotypically characterize dengue virus (DENV) isolates among dengue-infected children from 2012–13/2014–15 outbreaks in southern India.
Syed Fazil Ahamed   +7 more
doaj   +1 more source

Expected versus observed DENV-2 and DENV-4 cases.

open access: yes, 2016
The observed age distribution of cases of DENV-2 (dark green in panels A, C, and D) and DENV-4 (dark purple in panel B). Using the ages of all febrile individuals that participated in a clinic-based febrile surveillance study[17], we built an empirical ...
Angelica Espinoza (2137915)   +12 more
core   +1 more source

Computational identification of Vernonia cinerea-derived phytochemicals as potential inhibitors of nonstructural protein 1 (NSP1) in dengue virus serotype-2

open access: yesFrontiers in Pharmacology
BackgroundDengue virus (DENV) infection, spread by Aedes aegypti mosquitoes, is a significant public health concern in tropical and subtropical regions.
Md. Shohel Hossain   +16 more
doaj   +1 more source

Increased cross-reactive DENV-specific PCs during acute secondary DENV infections.

open access: yes, 2012
A. Number of DENV-3-specific ASCs and total ASCs circulating in the peripheral blood during 2° DENV-3 infections. PBMCs from day 6 post-onset of symptoms from 33 patients enrolled with 2° DENV-3 infections were prepared and frozen in liquid nitrogen ...
Eva Harris (27355)   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy